These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 1423817)

  • 1. Tissue factor as a tumor procoagulant.
    Rao LV
    Cancer Metastasis Rev; 1992 Nov; 11(3-4):249-66. PubMed ID: 1423817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood coagulation and its alterations in hemorrhagic and thrombotic disorders.
    Rapaport SI
    West J Med; 1993 Feb; 158(2):153-61. PubMed ID: 8434467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvesicle-associated tissue factor and Trousseau's syndrome.
    Del Conde I; Bharwani LD; Dietzen DJ; Pendurthi U; Thiagarajan P; López JA
    J Thromb Haemost; 2007 Jan; 5(1):70-4. PubMed ID: 17239164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
    Sandset PM; Abildgaard U
    Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of tissue factor-factor VIIa expression on cell surfaces: a role for tissue factor-factor VIIa endocytosis.
    Rao LV; Pendurthi UR
    Mol Cell Biochem; 2003 Nov; 253(1-2):131-40. PubMed ID: 14619963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation proteases and human cancer.
    Sampson MT; Kakkar AK
    Biochem Soc Trans; 2002 Apr; 30(2):201-7. PubMed ID: 12023851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor on cells.
    Rao LV; Pendurthi UR
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S27-35. PubMed ID: 9819026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte procoagulant activity induced by adherence to an artificial surface is reduced by end-point immobilized heparin-coating of the surface.
    Barstad RM; Hamers MJ; Møller AS; Sakariassen KS
    Thromb Haemost; 1998 Feb; 79(2):302-5. PubMed ID: 9493580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor and the extrinsic pathway of coagulation during infection and vascular inflammation.
    Carson SD; Johnson DR; Tracy SM
    Eur Heart J; 1993 Dec; 14 Suppl K():98-104. PubMed ID: 8131798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction.
    Steppich B; Mattisek C; Sobczyk D; Kastrati A; Schömig A; Ott I
    Thromb Haemost; 2005 Jan; 93(1):35-9. PubMed ID: 15630488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of tissue factor in atherothrombosis].
    Grybauskas P
    Medicina (Kaunas); 2003; 39(12):1165-70. PubMed ID: 14704504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line.
    Drake TA; Ruf W; Morrissey JH; Edgington TS
    J Cell Biol; 1989 Jul; 109(1):389-95. PubMed ID: 2663880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase procoagulant activity in cancer progression.
    Nadir Y; Brenner B
    Thromb Res; 2016 Apr; 140 Suppl 1():S44-8. PubMed ID: 27067977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue Factor Prothrombotic Activity Is Regulated by Integrin-arf6 Trafficking.
    Rothmeier AS; Marchese P; Langer F; Kamikubo Y; Schaffner F; Cantor J; Ginsberg MH; Ruggeri ZM; Ruf W
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1323-1331. PubMed ID: 28495929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
    Almus FE; Rao LV; Rapaport SI
    Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.
    Sevinsky JR; Rao LV; Ruf W
    J Cell Biol; 1996 Apr; 133(2):293-304. PubMed ID: 8609163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer.
    Falanga A; Schieppati F; Russo D
    Semin Thromb Hemost; 2015 Oct; 41(7):756-64. PubMed ID: 26408922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving role of tissue factor and its pathway inhibitor.
    Doshi SN; Marmur JD
    Crit Care Med; 2002 May; 30(5 Suppl):S241-50. PubMed ID: 12004243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.